Ketamine was linked to a sustained reduction in suicidal ideation in depressed patients, with effects lasting up to 270 days, according to new research using electronic health records.

Nature Reviews Neuroscience - Rapid-acting antidepressant interventions, such as ketamine and psilocybin, are thought to enhance neural plasticity. This Review outlines evidence of synaptic...

University of Arizona researchers uncovered how levodopa-induced dyskinesia disrupts motor cortex function in Parkinson’s patients. Exploring ketamine as a treatment, they found it promotes neuroplasticity and restores control over movement.

A small, preliminary study suggests that a single intramuscular ketamine injection may rapidly ease symptoms in patients with treatment-resistant obsessive-compulsive disorder.